Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Puretech Health Plc ADR (NQ: PRTC )

21.90 +0.12 (+0.55%)
Streaming Delayed Price Updated: 10:55 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Puretech Health Plc ADR

< Previous 1 2 3 4 5 6 7 8 Next >
PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of... 
Via Benzinga
Earnings Scheduled For August 24, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is... 
Via Benzinga
PureTech Health plc – Half-Year Report
From PureTech Health plc
Via Business Wire
PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
From PureTech Health plc
Via Business Wire
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
From PureTech Health plc
Via Business Wire
Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition
Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107... 
Via Benzinga
PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome
From PureTech Health plc
Via Business Wire
PureTech: Notice of Half-Yearly Results
From PureTech Health plc
Via Business Wire
The Week In SPAC News - Sunday, July 25
In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled. 
Via Talk Markets
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's... 
Via Benzinga
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile Platforms
From PureTech Health plc
Via Business Wire
PureTech Health To Test LYT-200 / Tislelizumab Combo In Difficult To Treat Cancer
PureTech Health plc (NASDAQ: PRTC) has announced a clinical trial and supply agreement with an affiliate of BeiGene Ltd (NASDAQ: BGNE). The partnership... 
Via Benzinga
PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease
From PureTech Health plc
Via Business Wire
Vedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inflammatory Bowel Disease, at the International Human Microbiome Consortium Congress 2021 (IHMC)
From Vedanta Biosciences
Via Business Wire
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
From PureTech Health plc
Via Business Wire
PureTech Adds Inflammatory Disease Candidates To Pipeline With Alivio Buyout
Four years after launching Alivio Therapeutics, PureTech Health plc (NASDAQ: PRTC) is bringing the hydrogel player back into the fold by acquiring the... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a... 
Via Benzinga
PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume... 
Via Benzinga
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
From PureTech Health plc
Via Business Wire
PureTech to Present at the Jefferies Virtual Healthcare Conference
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.